Skip to content
Aperlena

TED - Tenders Electronic Daily (Publications Office of the EU) verified 1 day ago Contract award

Italy - Influenza vaccines - ARIA_2026_011 open multi-lot procedure for the supply of influenza and pneumococcal vaccines for the 2026/2027 seasonal prevention campaign and RSV monoclonal antibody products for newborns

Original Italia - Vaccini antinfluenzali - ARIA_2026_011 Procedura aperta multilotto ai sensi dell’art. 71 del D.Lgs. n. 36/2023, per la fornitura di vaccini antinfluenzali e anti pneumococco per la campagna di prevenzione stagionale 2026/2027 e prodotti contro RSV con anticorpo monoclonare per neonati e servizi connessi.

Awarded Italy Medical equipment & pharmaceuticals

Buyer Azienda Regionale per l'Innovazione e gli Acquisti S.p.A.; CUCSA: Centrale Unica di Committenza e Soggetto Aggregatore; Azienda Zero

€37.5M awarded value · €37,528,300

Key facts

Published
Estimated value
€158.5M
€158,538,456
Procedure
Open procedure
  1. Published
  2. Awarded pending

TED - Tenders Electronic Daily (Publications Office of the EU) does not publish the date of this award. See the official notice

View the official notice Watch this tender

Bidding is closed. An award or a correction on this notice: an email when the register sees it. Log in

Awarded to

AstraZeneca S.p.A.; SANOFI S.r.l.; MSD ITALIA S.R.L.; PFIZER SRL

Awarded value
€37,528,300 38% under the estimate of the same lots
Bids received
11 over 9 lots

Summary

Machine-generated summary

ARIA (Azienda Regionale per l'Innovazione e gli Acquisti S.p.A.), together with CUCSA and Azienda Zero, awarded an open multi-lot procedure under Article 71 of Legislative Decree no. 36/2023. The contract covers the supply of influenza and pneumococcal vaccines for the 2026/2027 seasonal prevention campaign, including live attenuated trivalent spray vaccines, inactivated and high-dose trivalent vaccines, 21-valent and at least 20-serotype pneumococcal conjugate vaccines, and NIRSEVIBAM injectable solution in all available dosages. The winners are AstraZeneca S.p.A., SANOFI S.r.l., MSD ITALIA S.R.L. and PFIZER SRL. The awarded value is EUR 37,528,300 against an estimated value of EUR 158,538,456.25, meaning the awarded price is 76% below the estimate.

Description

ARIA_2026_011 Procedura aperta multilotto ai sensi dell’art. 71 del D.Lgs. n. 36/2023, per la fornitura di vaccini antinfluenzali e anti pneumococco per la campagna di prevenzione stagionale 2026/2027 e prodotti contro RSV con anticorpo monoclonare per neonati e servizi connessi. Lotto 1 - Vaccino antinfluenzale trivalente vivo attenuato in formulazione spray - ARIA; Lotto 4 - Vaccino antinfluenzale trivalente inattivato - ARIA; Lotto 16 - NIRSEVIBAM soluzione iniettabile - Tutti i dosaggi disponibili - ARIA; Lotto 19 - Vaccino pneumococcico coniugato 21 valente - ARIA; Lotto 20 - Vaccino pneumococcico coniugato con almeno 20 sierotipi - ARIA; Lotto 21 - Vaccino antinfluenzale trivalente vivo attenuato in formulazione spray - ASUIT; Lotto 22 - Vaccino antinfluenzale trivalente inattivato - ASUIT; Lotto 23 - Vaccino antinfluenzale trivalente ad alte dosi - ASUIT; Lotto 26 - NIRSEVIBAM soluzione iniettabile - Tutti i dosaggi disponibili - ASUIT

9 lots

Lot 1
Lotto 1 - Vaccino antinfluenzale trivalente vivo attenuato in formulazione spray - ARIA estimated €8,100,000 · 10 months
Lot 2
Lotto 4 - Vaccino antinfluenzale trivalente inattivato - ARIA estimated €4,500,000 · 10 months
Lot 3
Lotto 16 - NIRSEVIBAM soluzione iniettabile - Tutti i dosaggi disponibili - ARIA estimated €24,322,500 · 10 months
Lot 4
Lotto 19 - Vaccino pneumococcico coniugato 21 valente - ARIA estimated €4,080,000 · 10 months
Lot 5
Lotto 20 - Vaccino pneumococcico coniugato con almeno 20 sierotipi - ARIA estimated €17,042,500 · 10 months
Lot 6
Lotto 21 - Vaccino antinfluenzale trivalente vivo attenuato in formulazione spray - ASUIT estimated €135,000 · 10 months
Lot 7
Lotto 22 - Vaccino antinfluenzale trivalente inattivato - ASUIT estimated €157,500 · 10 months
Lot 8
Lotto 23 - Vaccino antinfluenzale trivalente ad alte dosi - ASUIT estimated €918,750 · 10 months
How tenders are scored
Price
Show 1 more lot
Lot 9
Lotto 26 - NIRSEVIBAM soluzione iniettabile - Tutti i dosaggi disponibili - ASUIT estimated €1,276,500 · 10 months

As the official notice states them.

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Report an error in this notice

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 day ago

What this market pays

The buyer has too few awards of its own in this sector, so this is the range of the last 2,000 awards for Medical equipment & pharmaceuticals in Italy.

This award
€37.5M
Estimated value
€158.5M
Median award
€305,467
Middle half of past awards
€10,496 to €1.3M

The award is larger than three in four past awards.

Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.

Azienda Regionale per l'Innovazione e gli Acquisti S.p.A.; CUCSA: Centrale Unica di Committenza e Soggetto Aggregatore; Azienda Zero

Italy

notices in the register
3
awards
2
awarded in total
€54.5M

Competition

tenders per lot on average (open and restricted procedures)
1.2
of those lots received a single tender
80%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

Recent awards

Market context

open now in Medical equipment & pharmaceuticals
8,093
median open notice
€311,276

Who wins in this market

Many suppliers

Italy · Medical equipment & pharmaceuticals

different companies won awards here
1,670
of the awards went to the three most frequent winners
3%
winners of the last 12 months were new here
1,375 of 1,439
buyers awarded contracts here
389

Based on 2,607 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners. New: no award from the same buyer or market in the two years before.

Competition

tenders per lot on average (open and restricted procedures)
1.9
of those lots received a single tender
38%
of the awards went to companies based in another country
1%
of the tenders came from another country
1%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

Similar tenders

Open now

Awarded before

Never miss a tender like this

259 new notices in Medical equipment & pharmaceuticals in Italy in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

Or follow just its CPV code, Influenza vaccines: an email when new tenders arrive under it, no account needed.

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
o
Open the result in a new tab
x
Set this result aside
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Index

Close
Log in

Language